Sitruk-Ware R - Search Results

1

Prolactin secretion in benign breast diseases.

Sitruk-Ware R, Clair F, Sterkers N, Ulmann A, Mauvais-Jarvis P. Sitruk-Ware R, et al. Gynecol Endocrinol. 1987 Jun;1(2):195-200. doi: 10.3109/09513598709030682. Gynecol Endocrinol. 1987. PMID: 3140581 Free article.

2

In vivo effects of progestins on prolactin secretion.

Sitruk-Ware R, Varin C, Clair F, Maugis E, Fermanian J, Mauvais-Jarvis P. Sitruk-Ware R, et al. J Clin Endocrinol Metab. 1985 Mar;60(3):575-8. doi: 10.1210/jcem-60-3-575. J Clin Endocrinol Metab. 1985. PMID: 3919048

3

Benign breast disease I: hormonal investigation.

Sitruk-Ware R, Sterkers N, Mauvais-Jarvis P. Sitruk-Ware R, et al. Obstet Gynecol. 1979 Apr;53(4):457-60. Obstet Gynecol. 1979. PMID: 571588

4

[Benign breast diseases: hormonal studies in 125 cases (author's transl)].

Mauvais-Jarvis P, Kuttenn F, Mowszowicz I, Sitruk-Ware R. Mauvais-Jarvis P, et al. Nouv Presse Med. 1977 Dec 24;6(44):4115-8. Nouv Presse Med. 1977. PMID: 600762 French.

5

Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women.

Plu-Bureau G, Thalabard JC, Sitruk-Ware R, Asselain B, Mauvais-Jarvis P. Plu-Bureau G, et al. Br J Cancer. 1992 Jun;65(6):945-9. doi: 10.1038/bjc.1992.198. Br J Cancer. 1992. PMID: 1616869 Free PMC article.

6

Risk factors for breast fibroadenoma in young women.

Sitruk-Ware R, Thalabard JC, Benotmane A, Mauvais-Jarvis P. Sitruk-Ware R, et al. Contraception. 1989 Sep;40(3):251-68. doi: 10.1016/0010-7824(89)90091-7. Contraception. 1989. PMID: 2766721

7

[Endocrine markers in benign breast diseases].

Thalabard JC, Sitruk-Ware R, Kuttenn F, Mauvais-Jarvis P. Thalabard JC, et al. Zentralbl Gynakol. 1986;108(6):354-8. Zentralbl Gynakol. 1986. PMID: 3716674 German.

8

Percutaneous progesterone use and risk of breast cancer: results from a French cohort study of premenopausal women with benign breast disease.

Plu-Bureau G, Lê MG, Thalabard JC, Sitruk-Ware R, Mauvais-Jarvis P. Plu-Bureau G, et al. Cancer Detect Prev. 1999;23(4):290-6. doi: 10.1046/j.1525-1500.1999.99032.x. Cancer Detect Prev. 1999. PMID: 10403900

9

The use of the antiprogestin RU486 (mifepristone) as an abortifacient in early pregnancy--clinical and pathological findings; predictive factors for efficacy.

Sitruk-Ware R, Thalabard JC, De Plunkett TL, Lewin F, Epelboin S, Mowszowicz I, Yaneva H, Tournaire M, Chavinie J, Mauvais-Jarvis P, et al. Sitruk-Ware R, et al. Contraception. 1990 Mar;41(3):221-43. doi: 10.1016/0010-7824(90)90065-4. Contraception. 1990. PMID: 2323217

10

Breast cancer and oral contraceptives: a review.

Clavel F, Benhamou E, Sitruk-Ware R, Mauvais-Jarvis P, Flamant R. Clavel F, et al. Contraception. 1985 Dec;32(6):553-69. doi: 10.1016/s0010-7824(85)80002-0. Contraception. 1985. PMID: 3912104 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters